The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2020

Filed:

Jul. 17, 2017
Applicant:

University of Technology, Sydney, Broadway, AU;

Inventors:

Ann Margaret Simpson, Killarney Heights, AU;

Chang Tao, Westmead, AU;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/12 (2006.01); C12N 5/071 (2010.01); A61K 35/407 (2015.01); A61K 38/28 (2006.01); A61K 38/45 (2006.01); C07K 14/62 (2006.01); C12N 15/85 (2006.01); A61K 35/12 (2015.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/1205 (2013.01); A61K 35/407 (2013.01); A61K 38/28 (2013.01); A61K 38/45 (2013.01); C07K 14/62 (2013.01); C12N 5/067 (2013.01); C12N 15/85 (2013.01); A61K 35/12 (2013.01); A61K 48/00 (2013.01); C12N 2501/33 (2013.01); C12N 2510/00 (2013.01); C12N 2830/20 (2013.01); C12Y 207/01002 (2013.01);
Abstract

The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.


Find Patent Forward Citations

Loading…